Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children

Pediatric Neurology

Volumn 38, Issue 1, 2008, Pages 20-26

  Konofal, Eric ^a,c   Lecendreux, Michel ^a,c   Deron, Juliette ^a   Marchand, Martine ^b   Cortese, Samuele ^a   Zaïm, Mohammed ^d   Mouren, Marie Christine ^a   Arnulf, Isabelle ^c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS SULFATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT RESPONSE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; CAREGIVERS; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; FERRITINS; FERROUS COMPOUNDS; HUMANS; IRON; MALE; PARENTS; PILOT PROJECTS; PLACEBOS; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 36549031652     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.08.014     Document Type: Article

References (25)

1. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105 (2000) 1158-1170
2. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57 (2005) 1215-1220
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. (1994), American Psychiatric Association, Washington, DC
4. Biederman J., and Faraone S. Attention-deficit/hyperactivity disorder. Lancet 366 (2005) 237-248 [Erratum in: Lancet 2006;367:210]
5. Beard J.L., Chen Q., Connor J., and Jones B.C. Altered monoamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 48 (1994) 621-624
6. Burhans M.S., Dailey C., Beard Z., Wiesinger J., Murray-Kolb L., Jones B.C., and Beard J.L. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci 8 (2005) 31-38
7. Konofal E., Lecendreux M., Arnulf I., and Mouren M.C. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158 (2004) 1113-1115
8. Cortese S., Konofal E., Lecendreux M., et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 28 (2005) 1007-1013
9. Walters A.S., LeBrocq C., Dhar A., and International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
10. Sever Y., Ashkenazi A., Tyano S., and Weizman A. Iron treatment in children with attention deficit hyperactivity disorder: a pilot report. Neuropsychobiology 35 (1997) 178-180
11. Wechsler D. Échelle d'intelligence de Wechsler pour enfants. 3rd ed. (1991), ECPA, Paris
12. DuPaul G.J., Power T.J., Anastopoulos A.D., and Reid R. ADHD Rating Scale-IV: checklists, norms, and clinical interpretation (1998), Guilford Press, New York
13. Conners C.K. A teacher rating scale for use in drug studies with children. Am J Psychiatry 126 (1969) 884-888
14. ADHD rating scale. French version (2003), Eli Lilly, Indianapolis, IN
15. Dugas M. Hyperactivity in the child. [In French] (1987), Presses Universitaires de France (PUF), Paris
16. National Institute of Mental Health. Clinical Global Impression Scale-NIMH (1985), National Institutes of Health, Bethesda, MD
17. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health. International Restless Legs Syndrome Study Group. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
18. Abbott R. The effects of iron supplementation on cognitive function in infants and children. Bibl Nutr Dieta 54 (1998) 67-75
19. Sachdev H., Gera T., and Nestel P. Effect of iron supplementation on mental and motor development in children: systematic review of randomised controlled trials. Public Health Nutr 8 (2005) 117-132
20. Logan S., Martins S., and Gilbert R. Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency. Cochrane Database Syst Rev (2001) CD001444
21. Metallinos-Katsaras E., Valassi-Adam E., Dewey K.G., Lönnerdal B., Stamoulakatou A., and Pollitt E. Effect of iron supplementation on cognition in Greek preschoolers. Eur J Clin Nutr 58 (2004) 1532-1542
22. Bruner A.B., Joffe A., Duggan A.K., Casella J.F., and Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 348 (1996) 992-996
23. Pearson H.A., Ehrenkranz R.A., Rinder H.M., and Riely C.A. Hemosiderosis in a normal child secondary to oral iron medication. Pediatrics 105 (2000) 429-431
24. Spencer T., Heiligenstein J.H., Biederman J., et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63 (2002) 1140-1147
25. Millichap J.G., Yee M.M., and Davidson S.I. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 34 (2006) 200-203